US Bancorp’s MediWound MDWD Stock Holding History

US Bancorp’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-134	Closed	-$2.38K	–	4306
2024 Q4	$2.38K	Hold	134	–	–	﹤0.01%	3823
2024 Q3	$2.42K	Sell	134 -266	-67%	-$4.86K	﹤0.01%	3736
2024 Q2	$6.21K	Buy	+400	New	+$6.61K	﹤0.01%	3446

Other funds holding MDWD

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

US Bancorp's MDWD Position: Q1 2025 in Review

US Bancorp sold out of MediWound (MDWD) in Q1 2025, closing a stake of 134 shares — an estimated $2.38K sold.

US Bancorp first reported a position in MDWD in Q2 2024 and held it in 3 quarters. The position peaked at $6.21K in Q2 2024. 64 funds tracked by Wall St. Rank hold MDWD as of Q1 2025.

US Bancorp reported no remaining MediWound position as of Q1 2025 after selling out during the quarter.
US Bancorp sold 134 MediWound shares in Q1 2025, an estimated $2.38K.
US Bancorp first reported a position in MediWound in Q2 2024 and held it in 3 quarters.
US Bancorp's MediWound position peaked at $6.21K in Q2 2024.
64 funds tracked by Wall St. Rank held MediWound as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.